
LivaNova PLC LIVN
$ 60.47
0.62%
Annual report 2025
added 02-25-2026
LivaNova PLC Total Non Current Liabilities 2011-2026 | LIVN
Annual Total Non Current Liabilities LivaNova PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 516 M | 549 M | 283 M | 286 M | 7.92 M | 5.19 M | 5.45 M | 5.4 M | 6.88 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 549 M | 5.19 M | 185 M |
Quarterly Total Non Current Liabilities LivaNova PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.25 M | 8.25 M | 7.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.25 M | 7.92 M | 8.14 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
424 M | $ 13.26 | 1.14 % | $ 1.79 B | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.67 | 2.79 % | $ 382 M | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
8.87 K | $ 25.74 | 0.12 % | $ 218 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.09 | 2.21 % | $ 1.27 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.36 | 1.05 % | $ 126 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 57.19 | 1.87 % | $ 1.68 B | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.24 | 0.54 % | $ 318 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | 0.7 % | $ 38 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.07 | 3.88 % | $ 18.1 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
1.76 M | $ 2.08 | 0.2 % | $ 5.77 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 15.41 | 2.32 % | $ 362 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
13 B | $ 307.2 | -2.52 % | $ 117 B | ||
|
TransMedics Group
TMDX
|
34.5 M | $ 101.25 | 0.46 % | $ 3.44 B | ||
|
Tandem Diabetes Care
TNDM
|
31.7 M | $ 19.98 | 2.3 % | $ 1.36 B | ||
|
Globus Medical
GMED
|
18.2 M | $ 90.77 | 0.65 % | $ 12.3 B | ||
|
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 37.22 | 1.53 % | $ 1.16 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 88.24 | -0.31 % | $ 3.07 B | ||
|
Vivos Therapeutics
VVOS
|
587 K | $ 0.84 | 4.35 % | $ 8.63 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 84.0 | 0.6 % | $ 49.1 B | ||
|
LENSAR
LNSR
|
3.44 M | $ 5.21 | -0.38 % | $ 62.3 M | ||
|
Pulmonx Corporation
LUNG
|
25 M | $ 1.33 | 3.52 % | $ 54.1 M | ||
|
MiMedx Group
MDXG
|
65.4 M | $ 3.57 | 6.25 % | $ 528 M |